107 related articles for article (PubMed ID: 20001393)
1. Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population.
Mazza A; Zamboni S; Rubello D; Schiavon L; Zorzan S; Casiglia E
Blood Press; 2010 Apr; 19(2):67-74. PubMed ID: 20001393
[TBL] [Abstract][Full Text] [Related]
2. Pulse pressure amplification a mechanical biomarker of cardiovascular risk.
Benetos A; Thomas F; Joly L; Blacher J; Pannier B; Labat C; Salvi P; Smulyan H; Safar ME
J Am Coll Cardiol; 2010 Mar; 55(10):1032-7. PubMed ID: 20202520
[TBL] [Abstract][Full Text] [Related]
3. Pulse hypertension: a new component of the metabolic syndrome in elderly women?
Mazza A; Zamboni S; Tikhonoff V; Scarpa R; Cuppini S; Zennaro R; Pessina AC; Casiglia E
J Hum Hypertens; 2007 Dec; 21(12):934-41. PubMed ID: 17568753
[TBL] [Abstract][Full Text] [Related]
4. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
5. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll.
Casiglia E; Mazza A; Tikhonoff V; Pavei A; Privato G; Schenal N; Pessina AC
J Hum Hypertens; 2002 Jan; 16(1):21-31. PubMed ID: 11840226
[TBL] [Abstract][Full Text] [Related]
6. Pulse pressure monitoring of open antihypertensive therapy.
Safar ME; Vaisse B; Blacher J; Rudnichi A; Mourad JJ
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1088-94. PubMed ID: 15607613
[TBL] [Abstract][Full Text] [Related]
7. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures.
Greenberg J
Am J Hypertens; 2005 Aug; 18(8):1033-9. PubMed ID: 16109316
[TBL] [Abstract][Full Text] [Related]
9. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
[TBL] [Abstract][Full Text] [Related]
10. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes.
Kostis JB; Wilson AC; Freudenberger RS; Cosgrove NM; Pressel SL; Davis BR;
Am J Cardiol; 2005 Jan; 95(1):29-35. PubMed ID: 15619390
[TBL] [Abstract][Full Text] [Related]
13. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
14. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
Tantucci C; Donati P; Nicosia F; Bertella E; Redolfi S; De Vecchi M; Corda L; Grassi V; Zulli R
Respir Med; 2008 Apr; 102(4):613-9. PubMed ID: 18083020
[TBL] [Abstract][Full Text] [Related]
15. The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population.
Barengo NC; Kastarinen M; Antikainen R; Nissinen A; Tuomilehto J
J Hum Hypertens; 2009 Dec; 23(12):808-16. PubMed ID: 19369956
[TBL] [Abstract][Full Text] [Related]
16. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
18. Correlates of mortality in elderly COPD patients: focus on health-related quality of life.
Antonelli-Incalzi R; Pedone C; Scarlata S; Battaglia S; Scichilone N; Forestiere F; Bellia V
Respirology; 2009 Jan; 14(1):98-104. PubMed ID: 19144055
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.
Curkendall SM; DeLuise C; Jones JK; Lanes S; Stang MR; Goehring E; She D
Ann Epidemiol; 2006 Jan; 16(1):63-70. PubMed ID: 16039877
[TBL] [Abstract][Full Text] [Related]
20. [Heart failure: critical patients].
Fabbri G; Gorini M; Maggioni AP; Oliva F;
G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
